February 9, 2017
PrEP Biopharm’s asthma study misses goal, but gives useful insights
PrEP Biopharm’s study of its drug, earlier confirmed helpful for influenza and human rhinoviruse (HRV), has been undertaken to test its efficacy of the people with asthma, and check for different dosage, showed varying results.